梅州没有怀孕为什么月经迟迟来(梅州微创打胎手术多少钱) (今日更新中)

Gov. Whitmer (D-MI) jokes before going live: "It's not just Shark Week ... it's Shark Week *mouths expletive*" pic.twitter.com/KSndbTvLZi— The Recount (@therecount) August 18, 2020 188

Genetic testing company 23andMe has been given federal approval to sell at-home kits that test for three breast cancer gene mutations.This will be the first direct-to-consumer DNA test for these particular breast cancer gene mutations, the Food and Drug Administration said on Tuesday.A spokeswoman for 23andMe said the test for the three BRCA1/BRCA2 breast cancer gene mutations will be added "in the coming weeks" to the broader Health + Ancestry services, with no increase to the existing 9 cost.The test can only detect three out of more than 1,000 known BRCA mutations, according to the FDA. The BRCA1/BRCA2 hereditary mutations occur in about 2% of Ashkenazi Jewish women, but rarely occur in anyone else, the agency said in a press release."The test also does not provide information on a person's overall risk of developing any type of cancer," the FDA added.23sandMe already tests for genetic health risks for diseases like Parkinson's and Alzheimer's, along with wellness reports for things like lactose intolerance and saturated fat, and ancestral composition including Neanderthal ancestry.In 2013, the FDA ordered the company to stop sales of its home-testing kits, saying the Alphabet-backed company had failed to prove the validity of its product.Related: 23andMe gets funding for drug developmentAnne Wojcicki, who founded the company in 2006, called the FDA shutdown a "transformative moment" that prompted 23andMe to branch into drug development."Thank you to the FDA for hard work and progress on innovation," she tweeted on Tuesday.In 2015, 23andMe received approval from the FDA to test customers for whether they are carriers of certain disease-carrying genes that could be passed on to their children. In early 2017, the company received approval to issue genetic health risk reports.In September of last year, the company said it received 0 million in funding from Sequoia Capital to develop drugs based on user DNA.The-CNN-Wire? & ? 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved. 2050

GODDARD, Kan. (AP) — Authorities discovered a camel, a cow and a donkey roaming together along a Kansas road in a grouping reminiscent of a Midwestern Christmas Nativity scene.The Goddard Police Department asked for help Sunday in locating the owners of the “three friends traveling together (towards a Northern star).”Police said in a Facebook post that if they couldn’t find the owners, they would be “halfway toward a live Nativity this Christmas season.”Sedgwick County Sheriff’s Lt. Tim Meyers says the animals belong to an employee of the nearby Tanganyika Wildlife Park.One person who replied to the Facebook post inquired, “Are there 3 wise looking men near?” Another speculated that they “may lead you to the Second Coming.”Goddard is about 15 miles (24 kilometers) west of Wichita. 799

Health officials nationwide – and in the Kansas City metro – are warning about heart condition in recovering COVID-19 patients that could have more of an effect on athletes.Myocarditis, which inflames the heart muscle, is being called the "breaking news" of coronavirus."[Myocarditis] can lead to a thinning and distension of the heart and a lack of function in the heart," said Dr. Steve Stites, chief medical officer at the University of Kansas Health System, "And even to heart failure and the need for a heart transplant and bad heart rhythms that can lead to death."The condition could be exacerbated by the type of exercise athletes are used to."In college athletics, we don't know the outcome of myocarditis," Stites said. "We don't know that a high impact sport could worsen the damage to the heart. We don't know what high-intensity exercise might be doing to a heart that's already slightly inflamed. All of those are leading to questions about the safety of returning to high-performance sports."The hospital and health professionals around the U.S. are screening athletes to better understand how myocarditis affects the organs."Our fear is that we could be missing a lot of diseases that we can't see and we can't test for," Stites said, "and that can include very small blood vessel clots inside the heart that lead to more heart damage."Doctors at KU plan to make an assessment of how this will affect college and high school sports in the coming weeks.A study in Germany that looked at 100 patients recovering from COVID-19 found that 60% of them had myocarditis independent of preexisting conditions.Doctors at KU said the condition hasn't been studied as much in the U.SThis story was originally reported by Sarah Plake at KSHB. 1754

Health and Human Services Secretary Alex Azar said in a CNBC interview on Wednesday that government-funded coronavirus vaccines would be provided for free or at an affordable cost for the American public.Azar’s declaration comes as the government announced on Wednesday an agreement with Pfizer valued at .95 billion. An agreement stipulates that Pfizer would produce 100 million doses of a coronavirus vaccine for the US government to distribute as soon as one is ready.President Donald Trump added on Wednesday that after an initial 100 million doses are distributed, another 500 million doses would be received by the US government soon thereafter.“Hopefully, the approval process will go very quickly,” Trump said about getting the initial batch of 100 million vaccines. “And we think we have a winner there. We also think we have other companies right behind that are doing very well on the vaccines — long ahead of schedule.”But questions on who would get the vaccine remains a question. But the government vowed Wednesday that vaccines would be affordable."We will ensure that any vaccine that we're involved in sponsoring is either free to the American people or is affordable," Azar said.On Tuesday, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said in an interview with CNN’s Jake Tapper that he is encouraged by multiple vaccine candidates, and believes that things are still on track for a vaccine to be ready for production around the end of 2020 or start of 2021.“I think the timetable that we have discussed now over the past several months, luckily and fortunately, has really worked out OK,” Fauci said. “The results of several of the phase one trials of different candidates, not only one -- I'm reluctant to point out one that's going to be better than the other, because the proof of the pudding is whether it actually works in the field and is a safe and effective vaccine.” 1950

来源：资阳报